🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Imagine raising $400 million and the asset you send into the clinic is a me-too EZH2 inhibitor. Who said biotech was dead?! #Treeline

🎙️ Rahul Chaturvedi talks with Stephanie Sirota, CBO & Partner at RTW Investments, LP, on biotech financing, policy risks, and why investing in transformational science still wins. A bold, insightful episode from #Biotech2050. 🎧 Listen: on.soundcloud.com/V6ATvnVqB9cbNY… #BiotechInvesting #LifeSciences

How to be a 90th percentile startup investor: - Wire money on time - Share launch announcements on social - Reply with words of affirmation to the occasional investor update - Do nothing to harm the company That's all it takes!

how often do hospitals turnover their MRIs? what happens to the old ones?

There's a time tested way to cement international alliances, and I shouldn't have to spell it out.

👏 we're doing the same for biotech/pharma as well!

when Boston mayor Wu says “...We take care of  potholes..."

if the FDA is using AI to evaluate drugs, why isn't pharma?

Just won an argument with my gf

best part of these plots is that they're always a gross underestimation of the true TAM

true

curious if lyndra's tech could make a comeback?

It has always puzzled me how much big pharma has neglected mental health. Current treatments are suboptimal at best, while the number of people suffering from depression, anxiety, addiction, and other mental health challenges continues to rise. The modern world is clearly toxic

This is true. Ansari was the least deserving MeToo target -- the woman who wrote about sleeping with him specified multiple times that he was very careful to always get affirmative consent -- but his career was one of the most damaged.

a good note for emerging mgrs who want raise from UK LPs haha

🔥 take: biotech winter is over: - seeing good, clin stage science get funded at markup - earlier science getting cash to go to the clinic - FDA still humming and faster reg paths emerging - pharma (esp EU/Asia) active in M&A ...most of the doom & gloom is a PR hangover IMHO

Good news. After 2 rounds of venetoclax, GO, + chemo, my daughter has had a complete response. No detectable signs of the tumor that had completely shut her eye, which she was dangerously close to losing. 🙏🏾 to the amazing team St. Jude & the community for helping us get here.

🎙️#Biotech2050 host Alok Tayi chats with Howard Fillit, MD & Mark Roithmayr of Alzheimer's Drug Discovery Foundation on how they’re reshaping Alzheimer’s R&D—from blood tests to biotech bets. Discover how mission meets innovation. 🎧 Listen now: on.soundcloud.com/6ghbo9RPn55ElT… #Alzheimers #DrugDiscovery #HealthcareFunding

@ADDFCEO & Dr. Fillit of ADDF joined Alok Tayi on Biotech2050 Podcast for a powerful convo on the future of Alzheimer’s innovation: – ADDF’s venture philanthropy model – Urgency of risk-taking in drug development – Innovation amid federal funding pressure bit.ly/4086SAc

My toddler just walked into the kitchen holding a bag of golf balls and asked if I wanted to play a game called, “golf balls everywhere”